Trials / Completed
CompletedNCT02429102
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of MT-8554 in healthy Caucasian subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-8554 | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-04-29
- Last updated
- 2025-12-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02429102. Inclusion in this directory is not an endorsement.